The Histone Deacetylase Inhibitor OBP-801 Exhibits Potent Anti-Tumor Activity Against Neuroblastoma

被引:0
|
作者
Kaneda, Daisuke [1 ]
Kikuchi, Ken [1 ,2 ]
Yagyu, Shigeki [1 ]
Iehara, Tomoko [1 ]
Sakai, Toshiyuki [3 ]
Hosoi, Hajime [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan
[2] Uji Takeda Hosp, Dept Pediat, Kyoto, Japan
[3] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kyoto, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OS6-1-2
引用
收藏
页码:S40 / S41
页数:2
相关论文
共 50 条
  • [31] Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor
    Kim, Dong Hoon
    Lee, Jiyong
    Kim, Kyung Noo
    Kim, Hye Jin
    Jeung, Hei Cheul
    Chung, Hyun Cheol
    Kwon, Ho Jeong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 356 (01) : 233 - 238
  • [32] Entinostat, a histone deacetylase inhibitor, enhances CAR-NK cell anti-tumor activity by sustaining CAR expression
    Jo, Dong-Hyeon
    Kaczmarek, Shelby
    Khan, Abrar Ul Haq
    Pervin, Jannat
    Clark, Diana M.
    Gadde, Suresh
    Wang, Lisheng
    Mccomb, Scott
    Visram, Alissa
    Lee, Seung-Hwan
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [33] Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation
    Liu, HL
    Chen, Y
    Cui, CH
    Zhou, JF
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (05) : 603 - 609
  • [34] Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation
    Hong-li Liu
    Yan Chen
    Guo-hui Cui
    Jian-feng Zhou
    Acta Pharmacologica Sinica, 2005, 26 : 603 - 609
  • [36] HKI46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells
    Wegener, Dennis
    Deubzer, Hedwig E.
    Oehme, Ina
    Milde, Till
    Hildmann, Christian
    Schwienhorst, Andreas
    Witt, Olaf
    ANTI-CANCER DRUGS, 2008, 19 (09) : 849 - 857
  • [37] The Novel Tubulin Polymerization Inhibitor MHPT Exhibits Selective Anti-Tumor Activity against Rhabdomyosarcoma In Vitro and In Vivo
    Mu, Yan
    Liu, Yin
    Li, Liwen
    Tian, Cong
    Zhou, Hongyu
    Zhang, Qiu
    Yan, Bing
    PLOS ONE, 2015, 10 (03):
  • [38] Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
    Vigushin, DM
    Ali, S
    Pace, P
    Ito, K
    Adcock, I
    Coombes, RC
    CLINICAL CANCER RESEARCH, 1999, 5 : 3777S - 3777S
  • [39] AB801 is a potent and selective AXL inhibitor that demonstrates significant anti-tumor activity in combination with standard of care therapeutics
    Paprcka, S.
    Sridhar, S.
    Goshayeshi, A.
    Park, E.
    Liu, S.
    Flores, R.
    Rocha, L.
    Miles, D.
    Lamani, M.
    Cho, S.
    Wang, N.
    Guan, Y.
    Chandrasekar, S.
    Kushwaha, R.
    Jafri, S.
    Kaplan, A.
    Stagnaro, E.
    Seitz, L.
    Kline, J.
    Fernandez-Salas, E.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S110 - S110
  • [40] GM101 in Combination with Histone Deacetylase Inhibitor Enhances Anti-Tumor Effects in Desmoplastic Microenvironment
    Chang, Han-Gyu
    Choi, Yong-Hyeon
    Hong, JinWoo
    Choi, Joung-Woo
    Yoon, A-Rum
    Yun, Chae-Ok
    CELLS, 2021, 10 (11)